@BioMotiv

Accelerating breakthrough discoveries into medicines, affiliated with The #HarringtonProject. #impinv #drugdevelopment #biotech #CLE

 Cleveland, OH
biomotiv.com
Joined November 2017
  • Tweets461
  • Following342
  • Followers295
83Media
Tuned in to a virtual discussion this afternoon with Commerce Secretary Wilbur Ross, who praised the resilience of #CLE-area businesses but sounded the alarm on the city’s poor response rate to the census. ⁦@GCPartnership⁩ crainscleveland.com/manufact…

U.S. Commerce Secretary: 'Cleveland will come back blazing once the lockdowns are lifted'

Commerce Secretary Wilbur Ross said Monday, June 15, that the region's industrial backbone and ongoing appeal to manufacturers will better position the state to rebound from the pandemic. He also...

crainscleveland.com
7
6
We are seeing more retooling in our manufacturing sector to combat COVID-19. Thank you, U.S. Cotton #InThisTogetherCLE #ChamberStrong #Cleveland company approved to make swabs for coronavirus testing cleveland.com/open/2020/04/c…

Cleveland company approved to make swabs for coronavirus testing

A new polyester-based Q-tip-type swab for COVID-19 testing made by Cleveland-based U.S. Cotton has been approved by the U.S. Food and Drug Administration.

cleveland.com
1
2
FDA authorizes #Athersys to initiate a pivotal clinical trial evaluating #MultiStem Cell Therapy in patients with #COVID19 induced #ARDS. businesswire.com/news/home/2…
8
47
10
107
#Athersys CEO Gil Van Bokkelen was on @FoxNews on @AmericasNewsroom sharing the Athersys story about our #COVID19 induced #ARDS program using #MultiStem cell therapy. $ATHX foxnews.com/health/cell-ther…

Cell therapy touted as possible coronavirus treatment by Cleveland biotech company

The coronavirus has killed more than 4,000 people in the United States so far, and the race is on to find a vaccine, along with other treatments, to save the lives of those who are already infected. 

foxnews.com
12
40
8
94
Advising a #COVID19 research initiative for #socialimpact. Your #COVID19 experience as a patient or caregiver can make a difference. Join the Study Covid Project (studycovid.org) to help leaders make smarter decisions. @fastercures @metrohealthCLE @diabetesdaily
2
2
A COVID-19 (coronavirus) vaccine is in development - but what’s the process and when will it be available? Dr. Robert Salata, Program Director, UH Roe Green Center for Travel Medicine & Global Health, explains. #COVID19 #coronavirus
5
9
2
21
Help #CLE’s most vulnerable by contributing to the Greater #Cleveland #COVID19 Rapid Response Fund today: bit.ly/CLEgives. #CLEresponds #COVID19OhioReady
9
10
It takes $2.5B+ and 10-20 years to take a drug from discovery to FDA approval - and this only happens to 0.02% of initial discoveries. To advance breakthroughs into medicines faster, we teamed up with Harrington Discovery Institute to launch #MorganStanleyGIFTCures.
1
9
3
20
Now that's what we're talkin' about! 🎉 OptiKira LLC received $1.6 million from the @sbirgov grant to develop its new therapy. See how this funding is expected to help people: bit.ly/2Wm0WVG @CityofCincy @BioMotiv
4
5
Congratulations to biotech company #OptiKira, a @BioMotiv company and client company of @BioECorp, on receiving a $1.6 million Phase II @NIA_SBIR grant to advance research in retinitis pigmentosa. bit.ly/2YXVYLl
1
2
#OptiKira, a #Cleveland biotech startup spun out from @BioMotiv, has received a $1.6 million Small Business Innovation Research grant. crainscleveland.com/health-c…
1
2
5
Good report that addresses the many elements, more than just $$$, required to advance academic discoveries into medicines. We need more creative and coordinated patient-focused models. Thanks for including @BioMotiv. @CF_Foundation @fastercures
Milken Institute
@MilkenInstitute26 Mar 2019
"Nonprofits are uniquely positioned to support the risky studies required for a drug to survive the Valley of Death—and they are doing just that." More in our latest report. bit.ly/2JGa2GH
2
5
An aging population and the more than doubling of new cases of #Alzheimer's disease and other dementias projected by midcentury has fueled demand for prevention of and treatment for these conditions trib.al/3PuQfQB
2
2
2
It's Rare Disease Day! See how the Ohio bioscience industry is working on treatments to benefit the 350 million people worldwide with a rare or orphan disease: biomotiv.com/blog-posts/2019… @BioMotiv @BioOhio
2
3
The ink just dried...it's official! Congrats to everyone involved in making this collaboration possible @UHhospitals and @UniofOxford. cleveland.com/business/2019/…
4
1
23
Today is #RareDiseaseDay and we're proud of companies like @AbeonaBio from @nationwidekids, @BioMotiv, @OhioStateMed, @myonexustx supported by @Rev1Ventures + @Cincy_Tech, @AveXisInc, @LumosPharma from @uofcincy for their work in bioscience bit.ly/2ViNdtu @BioOhio
6
11
We are proud to support #RareDiseaseDay and the #Ohio scientists and researchers who have dedicated their careers to developing treatments and cures that could change lives! @BioMotiv @PhRMA @IAmBiotech #ShowYourRare
John F Lewis Jr@johnflewisjr28 Feb 2019
Replying to @OhioLifeScience
@BioOhio celebrates World Rare Disease Day, TODAY. Ohio is playing a growing role in this area from Cinci to Cleveland to Columbus. Exciting summary businesswire.com/news/home/2… @JobsOhio @nationwidekids @CincyChildrens @UHRainbowBabies please celebrate the amazing change in lives!
1
#BioEClient @BioMotiv announces new #immunooncology #startup, TamRx bit.ly/2URNO5p #NEOhio #drugdevelopment
3
6
BioMotiv, Rutgers launch TamRx buff.ly/2WJkxeV
2
1
Rutgers scientists form immuno-oncology biotech to develop pipeline of TAM inhibitors endpts.com/rutgers-scientist…
2
2
Load more